What is the appropriate workup for a patient with elevated Aspergillus-specific antibodies and chronic cough?

Workup of Patient with Raised Aspergillus-Specific Antibodies and Chronic Cough

Begin by measuring serum total IgE immediately—if ≥500 IU/mL alongside your already elevated Aspergillus-specific IgE (≥0.35 kUA/L), proceed with complete ABPA workup including Aspergillus-specific IgG, blood eosinophil count, and thin-section chest CT to diagnose allergic bronchopulmonary aspergillosis. 1

Algorithmic Diagnostic Approach

Step 1: Confirm Essential Components

You already have elevated Aspergillus-specific antibodies. The 2024 ISHAM-ABPA Working Group guidelines provide the most current diagnostic framework 1:

Essential components required:

• A. fumigatus-specific IgE ≥0.35 kUA/L (you have this)
• Serum total IgE ≥500 IU/mL (measure this next)

If both essential components are present, proceed to Step 2. If total IgE is <500 IU/mL, ABPA is still possible but requires all other criteria to be fulfilled 1.

Step 2: Obtain Additional Diagnostic Components (Need Any Two)

Order the following tests:

1. A. fumigatus-specific IgG

   • Use lateral flow assay or enzyme immunoassay
   • Population-specific cut-offs: ≥27 mgA/L (India), ≥60 mgA/L (Japan), ≥40 mgA/L (UK)
   • If unavailable, use manufacturer recommendations 1

2. Blood eosinophil count

   • Positive if ≥500 cells/μL (can be historical) 1

3. Thin-section chest CT

   • Look specifically for: bronchiectasis, mucus plugging, high-attenuation mucus (HAM)
   • HAM is pathognomonic—confirms ABPA even if other criteria incomplete 1
   • Also assess for: fleeting opacities, finger-in-glove opacities, lung collapse 1

4. Pulmonary function tests to characterize disease severity 1

Step 3: Assess for Predisposing Conditions

Evaluate for underlying conditions:

• Asthma (most common)
• Cystic fibrosis
• Chronic obstructive lung disease
• Pre-existing bronchiectasis 1, 2

The diagnosis can be made even without these predisposing conditions if the clinico-radiological presentation is compatible 1.

Step 4: Consider Advanced Testing

If available, measure IgE against recombinant Aspergillus antigens:

• rAsp f1, f2, and f4
• Elevated levels support ABPA diagnosis and can serve as another diagnostic component 1
• Absence of these antibodies suggests allergic bronchopulmonary mycosis (ABPM) from non-Aspergillus fungi 1

Critical Diagnostic Pitfalls

False Positives to Exclude

Aspergillus-specific IgG can be elevated in:

• COPD patients
• Pulmonary tuberculosis
• Bronchiectasis without ABPA
• Chronic pulmonary aspergillosis 1

Recent research shows that increasing the ELISA cut-off from 10 to 25 AU/mL improves specificity from 83.5% to 92.8% while maintaining excellent sensitivity 3. One-third of healthy controls may have false-positive results 4, so always correlate positive serology with radiological findings.

When to Consider Alternative Diagnoses

If A. fumigatus-specific IgE is <0.35 kUA/L:

• Consider ABPM from other fungi (Alternaria, Cladosporium, Candida, Mucor, Bipolaris)
• Requires repeated fungal cultures (≥2 sputum or 1 BAL) growing the causative organism
• Confirm with fungus-specific IgE and total IgE ≥500 IU/mL 1

If total IgE is low despite other features:

• May occur with prior glucocorticoid treatment
• Seen in elderly patients
• Constitutively low baseline IgE 1
• ABPA remains possible if all other criteria fulfilled 1

Practical Considerations

Bronchoscopy is NOT routinely recommended for ABPA diagnosis 1. Reserve it for:

• Suspected ABPM requiring fungal culture confirmation
• Atypical presentations requiring tissue diagnosis
• Exclusion of alternative diagnoses

Geographic variations exist in Aspergillus-specific IgG cut-offs 5, so use population-specific thresholds when available or manufacturer recommendations as default 1.

The sensitivity of Aspergillus-specific IgG for chronic pulmonary aspergillosis is 85.1% with specificity of 83.6% when using histologically proven cases as reference 4. For ABPA specifically, the positivity rate reaches 97.9% in proven cases 6.